| 000 | 01815 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515023407.0 | ||
| 264 | 0 | _c20061003 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a0924-9338 | ||
| 024 | 7 |
_a10.1016/j.eurpsy.2004.09.030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLieb, Klaus | |
| 245 | 0 | 0 |
_aCognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study. _h[electronic resource] |
| 260 |
_bEuropean psychiatry : the journal of the Association of European Psychiatrists _cApr 2006 |
||
| 300 |
_a204-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnxiety Disorders _xchemically induced |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 |
_aDepressive Disorder _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuropsychological Tests _xstatistics & numerical data |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 | _aSelf-Assessment |
| 700 | 1 | _aEngelbrecht, Marc A | |
| 700 | 1 | _aGut, Oliver | |
| 700 | 1 | _aFiebich, Bernd L | |
| 700 | 1 | _aBauer, Joachim | |
| 700 | 1 | _aJanssen, Gesa | |
| 700 | 1 | _aSchaefer, Martin | |
| 773 | 0 |
_tEuropean psychiatry : the journal of the Association of European Psychiatrists _gvol. 21 _gno. 3 _gp. 204-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eurpsy.2004.09.030 _zAvailable from publisher's website |
| 999 |
_c16235912 _d16235912 |
||